Bajaj HealthCare Limited

NSEI:BAJAJHCARE Stock Report

Market Cap: ₹9.0b

Bajaj HealthCare Past Earnings Performance

Past criteria checks 2/6

Bajaj HealthCare has been growing earnings at an average annual rate of 10.3%, while the Pharmaceuticals industry saw earnings growing at 14.8% annually. Revenues have been growing at an average rate of 11.1% per year. Bajaj HealthCare's return on equity is 2.6%, and it has net margins of 1.6%.

Key information

10.3%

Earnings growth rate

10.3%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate11.1%
Return on equity2.6%
Net Margin1.6%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Bajaj HealthCare (NSE:BAJAJHCARE) Has Announced That Its Dividend Will Be Reduced To ₹1.00

Sep 10
Bajaj HealthCare (NSE:BAJAJHCARE) Has Announced That Its Dividend Will Be Reduced To ₹1.00

We Think That There Are More Issues For Bajaj HealthCare (NSE:BAJAJHCARE) Than Just Sluggish Earnings

Nov 19
We Think That There Are More Issues For Bajaj HealthCare (NSE:BAJAJHCARE) Than Just Sluggish Earnings

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Soars 30% But It's A Story Of Risk Vs Reward

Jan 17
Bajaj HealthCare Limited (NSE:BAJAJHCARE) Soars 30% But It's A Story Of Risk Vs Reward

Revenue & Expenses Breakdown
Beta

How Bajaj HealthCare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:BAJAJHCARE Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 235,211835000
30 Sep 235,4511954910
30 Jun 236,3923574880
31 Mar 236,7334304880
31 Dec 226,9065694710
30 Sep 227,1636334580
30 Jun 226,6636424140
31 Mar 226,7997144130
31 Dec 216,3647523890
30 Sep 216,4718423630
30 Jun 217,0288703620
31 Mar 216,5708313520
31 Dec 206,4407173470
30 Sep 205,6495143270
30 Jun 204,5813463010
31 Mar 204,1072522870
31 Dec 193,8211792750
30 Sep 193,7331662740
30 Jun 193,6731642520
31 Mar 193,7021632480
31 Dec 183,6881612400
30 Sep 183,6741582320
30 Jun 183,4721552260
31 Mar 183,2711522210
31 Dec 172,9681262150
30 Sep 172,6651002080
30 Jun 172,486892050
31 Mar 172,307782020
31 Dec 162,210681920
30 Sep 162,118581810
30 Jun 162,175701760
31 Mar 162,232821710
31 Mar 152,183751460
31 Mar 142,049201260

Quality Earnings: BAJAJHCARE has high quality earnings.

Growing Profit Margin: BAJAJHCARE's current net profit margins (1.6%) are lower than last year (8.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BAJAJHCARE's earnings have grown by 10.3% per year over the past 5 years.

Accelerating Growth: BAJAJHCARE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BAJAJHCARE had negative earnings growth (-85.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (23.8%).


Return on Equity

High ROE: BAJAJHCARE's Return on Equity (2.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.